Sign In
Buy MYOV
$26.98
+0 (+0%)
At Close: Jun 08, 2023
-$0.79 EPS Expected for Myovant Sciences Ltd (NYSE:MYOV) This Quarter
06:42am, Wednesday, 25'th Mar 2020
Equities research analysts predict that Myovant Sciences Ltd (NYSE:MYOV) will post ($0.79) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Zero analysts have issue
State Street Corp Increases Stock Holdings in Myovant Sciences Ltd (NYSE:MYOV)
08:08am, Tuesday, 24'th Mar 2020
State Street Corp lifted its position in Myovant Sciences Ltd (NYSE:MYOV) by 16.4% in the fourth quarter, HoldingsChannel reports. The firm owned 66,956 shares of the company’s stock after buying an
Insider Buying: Myovant Sciences Ltd (NYSE:MYOV) Major Shareholder Purchases $2,904,622.00 in Stock
08:22am, Monday, 23'rd Mar 2020
Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo purchased 387,800 shares of the stock in a transaction on Thursday, March 19th. The stock was acquired at an average cost
Chemical Co. Ltd. Sumitomo Buys 193,900 Shares of Myovant Sciences Ltd (NYSE:MYOV) Stock
08:38am, Friday, 20'th Mar 2020
Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo bought 193,900 shares of the company’s stock in a transaction dated Monday, March 16th. The stock was bought at an avera
Barclays PLC Has $408,000 Holdings in Myovant Sciences Ltd (NYSE:MYOV)
09:42am, Monday, 16'th Mar 2020
Barclays PLC raised its stake in Myovant Sciences Ltd (NYSE:MYOV) by 132.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional i
Myovant Sciences (NYSE:MYOV) Shares Down 8.4%
07:39am, Friday, 13'th Mar 2020
Myovant Sciences Ltd (NYSE:MYOV) shares were down 8.4% during trading on Wednesday . The stock traded as low as $8.65 and last traded at $8.70, approximately 854,304 shares traded hands during trading
Fmr LLC Invests $10.15 Million in Myovant Sciences Ltd (NYSE:MYOV)
10:33am, Wednesday, 11'th Mar 2020
Fmr LLC acquired a new position in Myovant Sciences Ltd (NYSE:MYOV) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). Th
Amia Capital LLP Invests $830,000 in Myovant Sciences Ltd (NYSE:MYOV)
09:44am, Wednesday, 11'th Mar 2020
Amia Capital LLP acquired a new position in shares of Myovant Sciences Ltd (NYSE:MYOV) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The i
Bristol-Myers Squibb's Multiple Myeloma Setback, And Other News: The Good, Bad And Ugly Of Biopharma
04:32pm, Tuesday, 10'th Mar 2020
Xenon pharma reported financial results. Myovant moves forward with relugolix. BMY suffers a setback with its MM drug.
BRIEF-Myovant Sciences Cancels Presentation At The Barclays Global Healthcare Conference 2020
01:11pm, Tuesday, 10'th Mar 2020
Myovant Sciences Ltd:
Myovant Sciences Announces Cancellation of Presentation and Webcast at the Barclays Global Healthcare Conference 2020
12:30pm, Tuesday, 10'th Mar 2020
BASEL, Switzerland, March 10, 2020 -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer,.
Myovant Sciences Ltd:
Myovant Sciences files application in Europe for relugolix combo tablet
01:16pm, Monday, 09'th Mar 2020
Myovant Sciences (NYSE:MYOV) has submitted a marketing application in Europe seeking approval to use a combination tablet formulation of relugolix (relugolix 40 mg, estradiol 1.0 mg, and norethindrone
Myovant Sciences submits MAA to EMA for relugolix combination tablet MYOV
01:08pm, Monday, 09'th Mar 2020
Myovant Sciences submits MAA to EMA for relugolix combination tablet MYOV
Myovant Sciences (MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer, today announced the submission of a Marketing Authorization Applicatio
